XML 27 R5.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
Research and development $ 41,110 $ 50,477
General and administrative 25,727 30,999
Total operating expenses 66,837 81,476
Other income (expense):    
Interest income 7,868 10,780
Other expense (32) (84)
Total other income 7,836 10,696
Net loss $ (59,001) $ (70,780)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.47) $ (0.56)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.47) $ (0.56)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) 126,256,583 125,426,509
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) 126,256,583 125,426,509